(Q38060574)

28 August 2017

1 reference

title

Use of proteomic methods in the analysis of human body fluids in Alzheimer research (English)

1 reference

28 August 2017

0 references

Petra Zürbig

1

0 references

Holger Jahn

object named as

Holger Jahn

series ordinal

2

0 references

language of work or name

1 reference

1 December 2012

1 reference

28 August 2017

1 reference

28 August 2017

volume

33

1 reference

28 August 2017

issue

24

1 reference

28 August 2017

page(s)

3617-3630

1 reference

Age-specific incidence of Alzheimer's disease in a community population.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

An Estimate of the Worldwide Prevalence and Direct Costs of Dementia in 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Alzheimer's disease: the challenge of the second century

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Novel MRI techniques in the assessment of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteomics in postgenomic neuroscience: the end of the beginning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

First analysis of the proteome in two nematomorph species, Paragordius tricuspidatus (Chordodidae) and Spinochordodes tellinii (Spinochordodidae).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Survey of bacterial proteins released in cheese: a proteomic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Towards characterization of the human urinary peptidome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Peptidomics technologies for human body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Peptidomics-Based Discovery of Novel Neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteomic research in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

A rapid method to capture and screen for transcription factors by SELDI mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Finding regions of significance in SELDI measurements for identifying protein biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Current developments in SELDI affinity technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

SELDI ProteinChip array in oncoproteomic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

“Western Blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Protein identification: the origins of peptide mass fingerprinting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Methods for fractionation, separation and profiling of proteins and peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteome profile of human urine with two-dimensional liquid phase fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Comparison of two proteomics techniques used to identify proteins regulated by gibberellin in rice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Application of surface-enhanced laser desorption/ionization technology to the detection and identification of urinary parvalbumin-alpha: a biomarker of compound-induced skeletal muscle toxicity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Peer Reviewed: SELDI-TOF MS for Diagnostic Proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteomic-based detection of urine proteins associated with acute renal allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Amyloid beta1-40 quantification in CSF: comparison between chromatographic and immunochemical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Monomer surface modifications for rapid peptide analysis by capillary electrophoresis and capillary electrochromatography coupled to electrospray ionization-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

On-line capillary electrophoresis-mass spectrometry for the analysis of biomolecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Recent advances in the application of capillary electrophoresis with mass spectrometric detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Urine profiling using capillary electrophoresis-mass spectrometry and multivariate data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Array of informatics: Applications in modern research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Absolute quantification of specific proteins in complex mixtures using visible isotope-coded affinity tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Peptide mapping of proteins in human body fluids using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Cerebrospinal fluid profile of amyloid beta peptides in patients with Alzheimer's disease determined by protein biochip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteomic analysis of Alzheimer's disease cerebrospinal fluid from neuropathologically diagnosed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer's disease and other dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Identification of oxidized plasma proteins in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteome-based plasma biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Serum biomarkers for Alzheimer's disease: proteomic discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Clinical proteomics: A need to define the field and to begin to set adequate standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Identification of a 5-protein biomarker molecular signature for predicting Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Mining biomarkers in human sera using proteomic tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Plasma biomarkers of brain atrophy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Multidimensional plasma protein separation technique for identification of potential Alzheimer's disease plasma biomarkers: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Developing a simple laboratory test for Alzheimer's disease: measuring acetylcholinesterase in saliva - a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Neuroproteases in peptide neurotransmission and neurodegenerative diseases: applications to drug discovery research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Histological and direct evidence for the role of complement in the neuroinflammation of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

A pilot study of urinary peptides as biomarkers for intelligence in old age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Proteomic analysis for the assessment of diabetic renal damage in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Detection of Acute Tubulointerstitial Rejection by Proteomic Analysis of Urinary Samples in Renal Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Running before we can walk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

Lessons learned from failed and discontinued clinical trials for the treatment of Alzheimer's disease: future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

7 January 2021

Biomarker discovery in urine by proteomics

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

7 January 2021

Identification of Peptide tumor markers in a tumor graft model in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

7 January 2021

Proteomic profiling of human urine using multi-dimensional protein identification technology

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

7 January 2021

A robust approach for the analysis of peptides in the low femtomole range by capillary electrophoresis-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

7 January 2021

An automated, sheathless capillary electrophoresis-mass spectrometry platform for discovery of biomarkers in human serum

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

7 January 2021

The pros and cons of multiplexing: a guest-editor's introduction

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

7 January 2021

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

7 January 2021

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

7 January 2021

Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

7 January 2021

The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201200360

7 January 2021

Identifiers

DOI

10.1002/ELPS.201200360

1 reference

28 August 2017

1 reference